Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study

被引:83
作者
Chubb, S. A. Paul [2 ,3 ]
Hyde, Zoe [3 ]
Almeida, Osvaldo P. [3 ,4 ]
Flicker, Leon [5 ]
Norman, Paul E. [6 ]
Jamrozik, Konrad [7 ]
Hankey, Graeme J. [5 ]
Yeap, Bu B. [1 ,5 ]
机构
[1] Fremantle Hosp, Sch Med & Pharmacol, Dept Endocrinol, Fremantle, WA 6160, Australia
[2] Fremantle Hosp, Dept Biochem, Fremantle, WA 6160, Australia
[3] Univ Western Australia, WA Ctr Hlth & Aging, Perth, WA 6009, Australia
[4] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia
[5] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia
[6] Univ Western Australia, Sch Surg & Pathol, Perth, WA 6009, Australia
[7] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA 5005, Australia
关键词
D O I
10.1530/EJE-07-0893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Reduced circulating testosterone and sex hormone-binding globulin (SHBG) Eire implicated as risk factors for metabolic syndrome. As SHBG increases with age while testosterone declines, we examined the relative contributions of SHBG and testosterone to the risk of metabolic syndrome in older men. Methods: We conducted a cross-sectional study of 2502 community-dwelling men aged >= 70 years without known diabetes. Metabolic syndrome was defined using the National Cholesterol Education Program-Third Adult Treatment Panel (NCEP-ATPIII) criteria. Early morning fasting sera were assayed for total testosterone, SHBG and LH. Free testosterone was calculated using mass action equations. Results: There were 602 men with metabolic syndrome (24.1%). The risk of metabolic syndrome increased for total testosterone < 20 nmol/l, SHBG < 50 nmol/l and free testosterone < 300 pmol/l. In univariate analyses SHBG was associated with all five components of metabolic syndrome, total testosterone was associated with all except hypertension, and free testosterone was associated only with waist circumference and triglycerides. In multivariate analysis, both total testosterone and especially SHBG remained associated with metabolic syndrome. with odds ratios of 1.34 (95% confidence interval (Cl): 1.18-1.52) and 1.77 (95%, Cl: 1.53-2.06) respectively Men with hypogonadotrophic hypogonadism (total testosterone < 8 nmol/l, LH <= 12 IU/l) had the highest prevalence of metabolic syndrome (53%. P<0.001). Conclusions: Lower SHBG is more strongly associated with metabolic syndrome than lower total testosterone in community-dwelling older men. SHBG may be the primary driver of these relationships, possibly reflecting its relationship with insulin sensitivity. Further studies should examine whether measures that raise SHBG protect against the development of metabolic syndrome in older men.
引用
收藏
页码:785 / 792
页数:8
相关论文
共 42 条
[1]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]   Sex steroids and all-cause and cause-specific mortality in men [J].
Araujo, Andre B. ;
Kupelian, Varant ;
Page, Stephanie T. ;
Handelsman, David J. ;
Bremner, William J. ;
McKinlay, John B. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (12) :1252-1260
[3]   Endogenous sex hormones and cognitive function in older men [J].
Barrett-Connor, E ;
Goodman-Gruen, D ;
Patay, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3681-3685
[4]   Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men [J].
Basu, Rita ;
Dalla Man, Chiara ;
Campioni, Marco ;
Basu, Ananda ;
Nair, K. Sreekumaran ;
Jensen, Michael D. ;
Khosla, Sundeep ;
Klee, George ;
Toffolo, Gianna ;
Cobelli, Claudio ;
Rizza, Robert A. .
DIABETES CARE, 2007, 30 (08) :1972-1978
[5]   The metabolic syndrome in frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism [J].
Bojesen, Anders ;
Kristensen, Kurt ;
Birkebaek, Niels H. ;
Fedder, Jens ;
Mosekilde, Leif ;
Bennett, Paul ;
Laurberg, Peter ;
Frystyk, Jan ;
Flyvbjerg, Allan ;
Christiansen, Jens S. ;
Gravholt, Claus H. .
DIABETES CARE, 2006, 29 (07) :1591-1598
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Use, misuse and abuse of androgens - The Endocrine Society of Australia consensus guidelines for androgen prescribing [J].
Conway, AJ ;
Handelsman, DJ ;
Lording, DW ;
Stuckey, B ;
Zajac, JD .
MEDICAL JOURNAL OF AUSTRALIA, 2000, 172 (05) :220-224
[8]   Analytical and physiological factors affecting the interpretation of serum testosterone concentration in men [J].
Diver, MJ .
ANNALS OF CLINICAL BIOCHEMISTRY, 2006, 43 :3-12
[9]  
Endre T, 1996, J HUM HYPERTENS, V10, P755
[10]   Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study [J].
Feldman, HA ;
Longcope, C ;
Derby, CA ;
Johannes, CB ;
Araujo, AB ;
Coviello, AD ;
Bremner, WJ ;
McKinlay, JB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :589-598